<DOC>
	<DOC>NCT00866411</DOC>
	<brief_summary>The purpose of this double-blind randomized control research study is to determine if CES given in a group setting for soldiers experiencing irritability is effective to reduce the symptom of irritability.</brief_summary>
	<brief_title>Cranial Electrotherapy Stimulation (CES) for Soldiers With Combat-Related Symptoms</brief_title>
	<detailed_description />
	<criteria>Soldiers over 18 years old or emancipated minors willing to sign an informed consent and complete all protocol requirements. Soldiers who score 4 or greater on the visual analog scale for irritability Seizure disorders. Pregnancy. All female Soldiers will verify in the informed consent that they are not currently pregnant. Safety of stimulation has not been established during pregnancy and therefore we will exclude women who are or want to become pregnant during the course of the study. Concomitant therapy with an investigational drug or device, or participation in an investigational drug or device study within one month prior to entering this study Patients with a pacemaker or implanted defibrillator. The AlphaStim 100 may effect the operation of cardiac pacemakers (particularly demand type pacemakers) and therefore this population will be excluded from this study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>cranial electrotherapy stimulation</keyword>
	<keyword>anxiety</keyword>
	<keyword>depression</keyword>
	<keyword>pain</keyword>
	<keyword>sleep disturbance</keyword>
	<keyword>combat exposure</keyword>
	<keyword>post traumatic stress</keyword>
	<keyword>health status</keyword>
	<keyword>medication use</keyword>
	<keyword>soldiers</keyword>
</DOC>